Interpace Biosciences Inc EV/EBIT
Qual é o EV/EBIT de Interpace Biosciences Inc?
O EV/EBIT de Interpace Biosciences Inc é 1.01
Qual é a definição de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT de empresas na Setor Health Care em NASDAQ em comparação com Interpace Biosciences Inc
O que Interpace Biosciences Inc faz?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Empresas com ev/ebit semelhantes a Interpace Biosciences Inc
- Recylex S.A tem EV/EBIT de 0.99
- Imunon Inc tem EV/EBIT de 1.00
- STM Plc tem EV/EBIT de 1.00
- A.P. Moller - Marsk A/S tem EV/EBIT de 1.00
- SandRidge Permian Trust tem EV/EBIT de 1.00
- Inozyme Pharma tem EV/EBIT de 1.01
- Interpace Biosciences Inc tem EV/EBIT de 1.01
- Ekotechnika Ag A O.N tem EV/EBIT de 1.02
- Cato tem EV/EBIT de 1.02
- Phio Pharmaceuticals tem EV/EBIT de 1.05
- United Oil & Gas Plc tem EV/EBIT de 1.05
- Virnetx Corp tem EV/EBIT de 1.07
- InMed Pharmaceuticals tem EV/EBIT de 1.07